HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.

AuthorsI Del Corso, I Puxeddu, E Sardano, S Geraci, M Breggia, V Rocchi, P Migliorini
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 108 Issue 6 Pg. 460-1 (Jun 2012) ISSN: 1534-4436 [Electronic] United States
PMID22626601 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Bradykinin B2 Receptor Antagonists
  • Receptor, Bradykinin B2
  • icatibant
  • Bradykinin
Topics
  • Angioedema (drug therapy, immunology, metabolism)
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Bradykinin (administration & dosage, analogs & derivatives, metabolism, therapeutic use)
  • Bradykinin B2 Receptor Antagonists
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Receptor, Bradykinin B2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: